Most lumps on a dog are nothing. Lipomas, warts, sebaceous cysts, histiocytomas that appear on a young dog's face and vanish on their own — the odds are genuinely in your favour. That's exactly the problem, because the one skin cancer you most want to catch early has made a career out of looking like all of them.
Mast cell tumors are the most common malignant skin tumor in dogs, and veterinary oncologists call them the great imitator for good reason. An MCT can present as a smooth raised bump, a soft squishy mass that feels exactly like a fatty lipoma, a red irritated patch, a wart-like nodule, or a lump that seems to swell and shrink from one week to the next. There is no appearance that rules it out. The only way to know what a lump is, is to put a needle in it.
What a Mast Cell Actually Is
Mast cells are normal, useful immune cells. They live throughout the skin, the airways and the gut lining, and they are packed with granules containing histamine, heparin and inflammatory enzymes. When they meet an allergen or a parasite, they degranulate — dumping those chemicals into the surrounding tissue. That's the mechanism behind a mosquito bite welt, a hive, and anaphylaxis.
A mast cell tumor is a mass of these cells that has become cancerous and grown out of control. What makes MCTs behave unlike other tumors is that the tumor cells keep their granules. Squeeze, bump or biopsy the mass and it can release a flood of histamine locally — which is why an MCT will sometimes redden, swell and itch dramatically within minutes of being handled. Clinicians call this Darier's sign, and while not every MCT shows it, it's close to a giveaway when it appears.
That same histamine release explains the systemic signs. Circulating histamine drives excess stomach acid, so dogs with MCTs sometimes present with vomiting, dark tarry stool from gastric ulceration, poor appetite or lethargy — occasionally before anyone has noticed the lump at all.
Which Dogs Are at Risk
A VetCompass study of more than 168,000 dogs in England found an overall MCT prevalence of 0.27%, with striking breed differences: Boxers at 1.95%, Golden Retrievers at 1.39% and Weimaraners at 0.85%. Age, body weight, neuter status and breed all correlated with diagnosis; sex did not.
The broad pattern most oncology services describe is that retrievers and brachycephalic breeds — Boxers, Boston Terriers, Pugs, Bulldogs — are over-represented, alongside Labrador Retrievers, Shar Peis, Rhodesian Ridgebacks and Staffordshire Bull Terriers. There's a useful nuance here: Boxers and Pugs get more MCTs, but they tend to get lower-grade, better-behaved ones. Shar Peis are the opposite, often developing aggressive tumors at a younger age.
Median age at diagnosis is around eight to nine years, but MCTs turn up in young dogs too. Age is not a reason to dismiss a lump.
Why the Needle Beats Waiting
A fine needle aspirate takes about thirty seconds, requires no sedation in most dogs, and costs a fraction of a biopsy. A small needle is inserted into the mass, cells are pulled onto a slide and stained. Mast cells have a distinctive appearance — round cells stuffed with purple granules — which makes MCT one of the easiest tumors to identify cytologically.
This is why the standard veterinary advice has hardened over the past decade from "keep an eye on it" to aspirate every new lump. "Watch and wait" costs nothing when the lump is a lipoma and costs a great deal when it isn't, because MCT surgery gets harder, larger and less likely to be curative as the mass grows and the margins needed expand with it.
Take a photo with a coin or ruler beside any lump you find, note the date, and get it aspirated. If your dog has multiple lumps — common in older Labradors — ask for each one to be checked individually and mapped. Mast cell tumors don't respect the assumption that all of a dog's lumps are the same thing.
Grade: The Number That Predicts Everything
Cytology tells you it's an MCT. Only histopathology — examining the removed tissue — tells you how it's likely to behave, and histologic grade is the single most reliable prognostic factor for cutaneous MCTs.
Two systems are used, usually together:
- The Patnaik system (1984) grades tumors I, II or III based on cell differentiation, cellularity, tissue involvement and mitotic count. Grade I is well differentiated and rarely spreads; grade III is anaplastic and aggressive.
- The Kiupel system (2011) is a simpler two-tier scheme — low grade or high grade — designed to fix the biggest weakness of Patnaik, which is that the majority of tumors landed in grade II, an unhelpfully wide middle category with unpredictable behaviour.
The combination is where the useful information lives. In one comparative series, every Patnaik grade I tumor was Kiupel low-grade and every grade III was high-grade — but among the grade II tumors, roughly 86% were reclassified as low-grade with a one-year survival probability of 94%, while the 14% reclassified as high-grade had a one-year survival of just 46%. Same grade II label; radically different futures.
Supplementary markers — Ki67 (a proliferation index), KIT staining pattern and c-KIT mutation testing — are often run on ambiguous tumors to refine the picture further, and c-KIT status also determines whether targeted drug therapy is likely to work.
Staging matters too. Depending on grade and location, your vet may recommend aspirating the local lymph node, an abdominal ultrasound with spleen and liver aspirates, and bloodwork. The purpose is to find out whether the disease has already travelled before committing to major surgery.
Treatment: Surgery First, Usually
For most MCTs, surgical removal is the treatment of choice and, for low-grade tumors excised completely, it's often curative on its own.
What matters is the margin. The traditional teaching was 3 cm laterally and one fascial plane deep; a systematic review of margin studies has supported somewhat more conservative margins — roughly 1–2 cm plus a deep fascial plane — for low-grade tumors, which spares a lot of skin on limbs where there isn't much to spare. The stakes are clear in the recurrence data: incompletely excised sites recurred locally in about 58% of cases versus 26% for clean margins.
Because degranulation during surgery can cause swelling, bleeding problems and low blood pressure, dogs are typically pre-treated with antihistamines such as diphenhydramine and acid blockers such as famotidine or omeprazole before and after the procedure.
When surgery alone isn't enough — high grade, dirty margins in a site that can't be re-cut, or lymph node involvement — the options are:
- Radiation therapy, the most effective adjuvant for incompletely excised cutaneous MCTs, with good long-term local control.
- Chemotherapy, most commonly vinblastine with prednisolone, or lomustine (CCNU). Recent work confirms grade and mitotic count remain prognostic even in dogs treated with vinblastine.
- Tyrosine kinase inhibitors — toceranib (Palladia) and masitinib — which target the KIT receptor. Dogs whose tumors carry an activating c-KIT mutation respond substantially better, which is why mutation testing is worth doing before starting.
- Tigilanol tiglate (Stelfonta), a plant-derived compound injected directly into the tumor, FDA-approved for non-metastatic cutaneous MCTs and subcutaneous MCTs at or below the elbow or hock. In the registration study, 75% of treated tumors had a complete response by day 28 after a single dose, with 93% of those still tumor-free at day 84. It leaves an open wound that heals by second intention over several weeks, which surprises owners who aren't warned — but it can rescue tumors in locations where surgery would mean amputation.
What to Take Away
A dog with a completely excised low-grade mast cell tumor usually goes on to live a normal life span and die of something else entirely. A dog with a high-grade tumor faces a much harder road. The difference between those two conversations is often just how early the lump got a needle in it.
So: check your dog over with your hands once a month — chest, belly, legs, under the tail, between the toes. Photograph and date anything new. And when you find something, resist the very reasonable instinct to wait and see. Most lumps are nothing. The whole point of the aspirate is to find the one that isn't.